Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
  2. Nussinov,Ruth; Jang,Hyunbum; Tsai,Chung-Jung; Cheng, Feixiong
  3. PLoS computational biology. 2019, Mar; 15(3):
  1. 2.   Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
  2. Ramonet, D.; Daher, J. P. L.; Lin, B. M.; Stafa, K.; Kim, J.; Banerjee, R.; Westerlund, M.; Pletnikova, O.; Glauser, L.; Yang, L. C.; Liu, Y.; Swing, D. A.; Beal, M. F.; Troncoso, J. C.; McCaffery, J. M.; Jenkins, N. A.; Copeland, N. G.; Galter, D.; Thomas, B.; Lee, M. K.; Dawson, T. M.; Dawson, V. L.; Moore, D. J.
  3. Plos One. 2011, Apr; 6(4):
  1. 3.   Implications for Gene Therapy-Limiting Expression of IL-2R gamma(c) Delineate Differences in Signaling Thresholds Required for Lymphocyte Development and Maintenance
  2. Orr, S. J.; Roessler, S.; Quigley, L.; Chan, T.; Ford, J. W.; O'Connor, G. M.; McVicar, D. W.
  3. Journal of Immunology. 2010, Aug; 185(3): 1393-1403.
  1. 4.   Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo
  2. Daniel, J. A.; Pellegrini, M.; Lee, J. H.; Paull, T. T.; Feigenbaum, L.; Nussenzweig, A.
  3. Journal of Cell Biology. 2008 183(5): 777-783.
  1. 5.   CDK2 is required by MYC to induce apoptosis
  2. Deb-Basu, D.; Aleem, E.; Kaldis, P.; Felsher, D. W.
  3. Cell Cycle. 2006, Jun; 5(12): 1342-1347.
  1. 6.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 7.   Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk
  2. Nishigaki, K.; Hanson, C.; Jelacic, T.; Thompson, D.; Ruscetti, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, OCT 25; 102(43): 15488-15493.
  1. 8.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 9.   Autophosphorylation of Archaeoglobus fulgidus Rio2 and crystal structures of its nucleotide-metal ion complexes
  2. Laronde-Leblanc, N.; Guszczynski, T.; Copeland, T.; Wlodawer, A.
  3. Febs Journal. 2005, JUN; 272(11): 2800-2810.
  1. 10.   Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex
  2. Medvedev, A. E.; Thomas, K.; Awomoyi, A.; Kuhns, D. B.; Gallin, J. I.; Li, X. X.; Vogel, S. N.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6587-6591.
  1. 11.   Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice
  2. Kim, H. W.; Park, I. K.; Cho, C. S.; Lee, K. H.; Beck, G. R.; Colburn, N. H.; Cho, M. H.
  3. Cancer Research. 2004, NOV 1; 64(21): 7971-7976.
  1. 12.   Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit
  2. Lennartsson, J.; Shivakrupa, R.; Linnekin, D.
  3. Journal of Biological Chemistry. 2004, OCT 22; 279(43): 44544-44553.
  1. 13.   Contribution of JNK, Mek, Mos and PI-3K signaling to GVBD in Xenopus oocytes
  2. Mood, K.; Bong, Y. S.; Lee, H. S.; Ishimura, A.; Daar, I. O.
  3. Cellular Signalling. 2004, MAY; 16(5): 631-642.
  1. 14.   The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation
  2. Angeloni, D.; Danilkovitch-Miagkova, A.; Miagkov, A.; Leonard, E. J.; Lerman, M. I.
  3. Journal of Biological Chemistry. 2004 279(5): 3726-3732.
  1. 16.   Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells
  2. Hodge, D. R.; Xiao, W. H.; Wang, L. H.; Li, D. P.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004 3(2): 188-194.
  1. 17.   Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos
  2. Park, E. K.; Warner, N.; Bong, Y. S.; Stapleton, D.; Maeda, R.; Pawson, T.; Daar, I. O.
  3. Molecular Biology of the Cell. 2004 15(4): 1647-1655.
  1. 18.   Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation
  2. Haan, S.; Ferguson, P.; Sommer, U.; Hiremath, M.; McVicar, D. W.; Heinrich, P. C.; Johnston, J. A.; Cacalano, N. A.
  3. Journal of Biological Chemistry. 2003 278(34): 31972-31979.
  1. 19.   cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia
  2. Hitzler, J. K.; Witte, D. P.; Jenkins, N. A.; Copeland, N. G.; Gilbert, D. J.; Naeve, C. W.; Look, A. T.; Morris, S. W.
  3. American Journal of Pathology. 1999 155(1): 53-59.
  1. 20.   Differential Control of the Phosphorylation State of Proline-Juxtaposed Serine Residues Ser(725) of Stat5a and Ser(730) of Stat5b in Prolactin-Sensitive Cells
  2. Yamashita, H.; Xu, J.; Erwin, R. A.; Farrar, W. L.; Kirken, R. A.; Rui, H. G.
  3. Journal of Biological Chemistry. 1998 273(46): 30218-30224.
  1. 21.   Determination of Flavopiridol (L86 8275 Nsc 649890) in Human Plasma By Reversed-Phase Liquid Chromatography With Electrochemical Detection
  2. Stinson, S. F.; Hill, K.; Siford, T. J.; Phillips, L. R.; Daw, T. W.
  3. Cancer Chemotherapy and Pharmacology. 1998 42(4): 261-265.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel